Colonial Trust Advisors’s AstraZeneca AZN Stock Holding History

Colonial Trust Advisors’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.58K	Hold	40	–	–	﹤0.01%	614
2026 Q1	$7.89K	Buy	40 +31	+344%	+$5.98K	﹤0.01%	561
2025 Q4	$1.66K	Hold	9	–	–	﹤0.01%	645
2025 Q3	$1.38K	Hold	9	–	–	﹤0.01%	630
2025 Q2	$1.26K	Hold	9	–	–	﹤0.01%	647
2025 Q1	$1.32K	Hold	9	–	–	﹤0.01%	630
2024 Q4	$1.18K	Hold	9	–	–	﹤0.01%	633
2024 Q3	$1.4K	Hold	9	–	–	﹤0.01%	696
2024 Q2	$1.4K	Sell	9 -51	-85%	-$7.67K	﹤0.01%	693
2024 Q1	$8.06K	Buy	60 +51	+567%	+$6.75K	﹤0.01%	630
2023 Q4	$1.21K	Hold	9	–	–	﹤0.01%	759
2023 Q3	$1.22K	Hold	9	–	–	﹤0.01%	765
2023 Q2	$1.29K	Buy	+9	New	+$1.32K	﹤0.01%	775

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Colonial Trust Advisors's AZN Position: Q2 2026 in Review

Colonial Trust Advisors held its AstraZeneca (AZN) position steady in Q2 2026 at 40 shares worth $7.58K. The position accounts for ﹤0.01% of the portfolio, ranked #614.

Colonial Trust Advisors first reported a position in AZN in Q2 2023 and has held it in 13 quarters since. The position peaked at $8.06K in Q1 2024. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Colonial Trust Advisors held 40 shares of AstraZeneca worth $7.58K as of Q2 2026.
Colonial Trust Advisors left its AstraZeneca share count unchanged in Q2 2026.
AstraZeneca made up ﹤0.01% of Colonial Trust Advisors's portfolio in Q2 2026, its #614 holding.
Colonial Trust Advisors first reported a position in AstraZeneca in Q2 2023 and has held it in 13 quarters since.
Colonial Trust Advisors's AstraZeneca position peaked at $8.06K in Q1 2024.
1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Colonial Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.